
501 - 1000 employees
Founded 2014
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

501 - 1000 employees
Founded 2014
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
• Responsible for submission planning, oversight of planning of IND related activities like Annual reports, Orphan drug reports, DSUR and other CTA activities for on-going study or study start-ups • Managing the planning, compilation, QC, and submission of Investigational Drug Applications (INDs), Biologics License Applications (BLAs), and their amendments. • Prepares routine IND and CTA amendments, for example, Annual Reports/DSURs, Investigator Packages, and SUSARs. • Independently, under limited supervision manages Vendors / CROs for planning and tracking of source documents to ensure high-quality IND, IND amendments, CTA, EU-CTR submissions are delivered in timely manner. • Support the implementation of regulatory strategy for assigned projects and programs for projects in all stages of development (IND through NDA/BLA approval and commercialization). • Works with submission authors and reviewers to ensure that source document planning is complete and that high-quality documents are approved on-schedule in terms of scientific content, organization, clarity, accuracy, format, consistency and adherence to regulatory guidelines, styles and processes. • Represents Regulatory Affairs and provides regulatory expertise to cross-functional teams on specified projects and topics. • Independently manages tracker for submissions across the multiple products. • Maintains logs of IND and CTA submissions and correspondence with FDA or other regulatory agencies. • Prepares templates or shells for specific submissions based on company standards. • Prepare and compile effective presentations for external and internal audiences as needed. • Other duties as assigned.
• BS degree required; advanced degree (PharmD, PhD, Master’s) preferred. Strong scientific or research background, with a focus in pharmacy, chemistry, or biology, preferred (or relevant experience). • Minimum 8 years’ experience in regulatory affairs or a related function in drug/biologic development. • Experience in managing regulatory submissions for investigational or marketed products to global health authorities in eCTD format a plus. • Understanding of US, and Ex-US including international regulations and procedures in drug/biologics development; familiarity with ICH and regional regulatory requirements. • Advanced skills in using Microsoft Office Suite (Word, PowerPoint, and Excel) and Adobe Acrobat Pro. • High attention to detail and accuracy. • High level of motivation and proactiveness required to engage in both in-person and remote team members. • Excellent interpersonal, verbal and written communication skills. • Ability to work independently with minimal supervision or direction • Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing priorities.
Apply Now🔥 5 hours ago
Regulatory Affairs Manager ensuring compliance with country-specific expanded access regulations globally for health tech company myTomorrows. Collaborating with Medical Affairs, Program Management, Quality Assurance, and Supply Chain.
🔥 12 hours ago
Global Regulatory Optimisation Lead defining and implementing EMC/RF competence development plans. Collaborating with global affiliates and regulatory authorities for EMC/RF business performance in North America.
🔥 15 hours ago
Learning Operations & Compliance Lead at JD Power managing Workday Learning and compliance training programs for effective learning ecosystems. Responsible for reporting, governance, and continuous improvement.
🔥 15 hours ago
Managerial role overseeing regulatory Chemistry Manufacturing Controls strategies at Syneos Health. Engaging in preparation and submission of regulatory documentation for small molecules.
🔥 16 hours ago
Lead Governance Risk Compliance Analyst creating audit methodologies and conducting risk assessments for Franciscan Health. Track and resolve audit findings while collaborating with teams.